Blockchain Registration Transaction Record

Kamada Expands Hyper-Immune Plasma Collection with New Facility in San Antonio

Kamada Ltd. expands its specialty hyper-immune plasma collection with the opening of a new plasma collection center in San Antonio, Texas. The company aims to receive FDA and EMA approvals for the facility within nine to twelve months. This strategic move is expected to lower raw material costs and strengthen Kamada's position in the specialty plasma-derived therapeutics market.

This news matters as Kamada's efforts to expand its plasma collection capabilities will not only meet the increasing demand for hyper-immune plasma products but also potentially lower raw material costs. By developing its own plasma collection centers, Kamada aims to reduce dependency on third-party suppliers, improve cost efficiency, and position itself as a key player in the specialty plasma-derived therapeutics field.